Today (16 November), the Moderna pharmaceutical company published phase 3 results for its mRNA vaccine indicating an estimated vaccine efficacy of 94.5%. Moderna’s vaccine may be...
The European Commission has concluded exploratory talks with Moderna to purchase a potential vaccine against COVID-19. Moderna is the fifth company with which the Commission has...
